La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Ardelyx Gestion
Gestion contrôle des critères 3/4
Le PDG Ardelyx's est Mike Raab, nommé en Mar2009, a un mandat de 15.42 ans. La rémunération annuelle totale est $ 4.12M, composée du salaire de 17% et des bonus 83%, y compris les actions et options de la société. détient directement 0.55% des actions de la société, d'une valeur de $ 7.51M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 4.2 ans et 8.8 ans.
Informations clés
Mike Raab
Directeur général
US$4.1m
Rémunération totale
Pourcentage du salaire du PDG | 17.0% |
Durée du mandat du directeur général | 15.4yrs |
Propriété du PDG | 0.5% |
Durée moyenne d'occupation des postes de direction | 4.2yrs |
Durée moyenne du mandat des membres du conseil d'administration | 8.8yrs |
Mises à jour récentes de la gestion
Recent updates
Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 07Ardelyx Faces Rising Challenges Despite Revenue Growth
Aug 05Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 04Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook
Jul 13Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge
Jul 05Ardelyx: Strong Execution, Fairly Valued
May 10Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 04Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)
May 03Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing
Apr 17Ardelyx Shrugs Off 'Mixed' Q4 Earnings
Mar 13Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Feb 24Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance
Feb 20Ardelyx's XPHOZAH Still An Afterthought To The Pros
Jan 31Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement
Jan 10Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price
Jan 04Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt
Dec 14Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 03Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
Jul 31Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now
Apr 17Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Mar 30Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Dec 14What To Expect For Ardelyx In The Coming Month
Oct 18Ardelyx: Potential For Growth, But Must Strengthen Its Financial Position
Oct 04Ardelyx secures $20M financial deal with HealthCare Royalty on tenapanor potential sale
Jun 30Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$65m |
Mar 31 2024 | n/a | n/a | -US$66m |
Dec 31 2023 | US$4m | US$700k | -US$66m |
Sep 30 2023 | n/a | n/a | -US$27m |
Jun 30 2023 | n/a | n/a | -US$56m |
Mar 31 2023 | n/a | n/a | -US$66m |
Dec 31 2022 | US$2m | US$650k | -US$67m |
Sep 30 2022 | n/a | n/a | -US$114m |
Jun 30 2022 | n/a | n/a | -US$135m |
Mar 31 2022 | n/a | n/a | -US$153m |
Dec 31 2021 | US$4m | US$650k | -US$158m |
Sep 30 2021 | n/a | n/a | -US$151m |
Jun 30 2021 | n/a | n/a | -US$125m |
Mar 31 2021 | n/a | n/a | -US$105m |
Dec 31 2020 | US$4m | US$633k | -US$94m |
Sep 30 2020 | n/a | n/a | -US$85m |
Jun 30 2020 | n/a | n/a | -US$91m |
Mar 31 2020 | n/a | n/a | -US$91m |
Dec 31 2019 | US$2m | US$595k | -US$95m |
Sep 30 2019 | n/a | n/a | -US$103m |
Jun 30 2019 | n/a | n/a | -US$104m |
Mar 31 2019 | n/a | n/a | -US$100m |
Dec 31 2018 | US$4m | US$575k | -US$91m |
Sep 30 2018 | n/a | n/a | -US$53m |
Jun 30 2018 | n/a | n/a | -US$50m |
Mar 31 2018 | n/a | n/a | -US$53m |
Dec 31 2017 | US$5m | US$555k | -US$64m |
Rémunération vs marché: La rémunération totale de Mike ($USD 4.12M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 5.62M ).
Rémunération et revenus: La rémunération de Mike a augmenté alors que l'entreprise n'est pas rentable.
PDG
Mike Raab (59 yo)
15.4yrs
Titularisation
US$4,118,144
Compensation
Mr. Michael G. Raab, also known as Mike, has been the Chief Executive Officer and President of Ardelyx, Inc. since March 2009. He is a Director of Tempest Therapeutics Inc. since May 2019 and its Chairman...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
President | 15.4yrs | US$4.12m | 0.55% $ 8.2m | |
Chief Legal & Administrative Officer and Secretary | 10.3yrs | US$1.63m | 0.085% $ 1.3m | |
Chief Medical Officer | 3.8yrs | US$1.63m | 0.14% $ 2.1m | |
Chief Financial & Operations Officer | 4.2yrs | US$1.73m | 0.13% $ 1.9m | |
Senior VP of Finance & Chief Accounting Officer | 2.4yrs | pas de données | 0.040% $ 606.0k | |
Vice President of Corporate Communications & Investor Relations | no data | pas de données | pas de données | |
Executive Vice President of Corporate Development & Strategy | less than a year | pas de données | pas de données | |
Chief Human Resources Officer | 1.6yrs | pas de données | pas de données | |
Chief Development Officer | 9.6yrs | US$1.63m | 0.25% $ 3.8m | |
Chief Regulatory Affairs & Quality Assurance Officer | no data | US$1.70m | 0.14% $ 2.1m | |
Advisor | 4.3yrs | US$1.04m | 0.19% $ 2.9m | |
Manager of Corporate Communications & Investor Relations | no data | pas de données | pas de données |
4.2yrs
Durée moyenne de l'emploi
60yo
Âge moyen
Gestion expérimentée: L'équipe de direction de ARDX est considérée comme expérimentée (ancienneté moyenne 4.2 ans).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
President | 15.4yrs | US$4.12m | 0.55% $ 8.2m | |
Independent Chairman of the Board | 15.4yrs | US$249.90k | 0.51% $ 7.7m | |
Independent Director | 8.8yrs | US$214.90k | 0.098% $ 1.5m | |
Independent Director | 10.4yrs | US$222.40k | 0.11% $ 1.6m | |
Independent Director | 8.2yrs | US$202.40k | pas de données | |
Independent Director | 4.4yrs | US$199.90k | 0.047% $ 701.7k | |
Independent Director | 3.4yrs | US$202.40k | 0.041% $ 610.2k |
8.8yrs
Durée moyenne de l'emploi
59yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de ARDX sont considérés comme expérimentés (ancienneté moyenne 8.8 ans).